Ulcerative Colitis Clinical Trials in Phoenix

Showing 201-220 of 587 trials

A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma

NCT06223048

The purpose of this research study is to assess the ability of AMDX- 2011P to identify amyloid deposits in the retina of participants with Primary Open Angle Glaucoma (POAG).

Primary Open Angle Glaucoma

Amydis Inc.50 participantsStarted Dec 2023

Phoenix, Arizona, United States • Glendale, California, United States • Newport Beach, California, United States

COMPLETED< 1 mile

Ambispective Clinical Evaluation of Sophono™

NCT03143257

Study to accumulate post-market clinical evidence for the safety and effectiveness of the Sophono Alpha 2 and Alpha 2 Maximum Power Output (MPO) systems in subjects diagnosed with conductive hearing loss, single-sided deafness and mixed hearing loss who currently have or have had the Sophono implant.

Conductive Hearing LossSingle-Sided DeafnessMixed Hearing Loss

Medtronic Surgical Technologies71 participantsStarted Jun 2017

Phoenix, Arizona, United States • Gainesville, Florida, United States • Jacksonville, Florida, United States +3 more locations

COMPLETED108 miles

Entyvio (Vedolizumab) Long Term Safety Study

NCT02674308

The purpose of this study is to assess the long-term safety of vedolizumab versus other biologic agents in participants with Ulcerative Colitis (UC) or Crohn's Disease (CD).

Ulcerative Colitis and Crohn's Disease

Takeda5,302 participantsStarted Mar 2015

Birmingham, Alabama, United States • Mobile, Alabama, United States • Tucson, Arizona, United States +284 more locations

A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma

Ambispective Clinical Evaluation of Sophono™

Entyvio (Vedolizumab) Long Term Safety Study

Ulcerative Colitis Trials in Other Cities

Study of OMNI System in OAG (GEMINI)

Observational Study of Obstructive Lung Disease (NOVELTY)

Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea

Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD

Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines

Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary

Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients

A Randomized, Double-blind, Placebo-controlled Study of Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy (DMD)

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)

Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Participants With Duchenne Muscular Dystrophy (DMD)

Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients

CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension

Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible Urticaria

Other Conditions in Phoenix